Search
forLearn
5 / 801 resultslearn Haritaki
learn Shatavari
learn Ashwagandha
learn Bibhitaki
Research
5 / 32 results
research THERAPEUTIC EFFICACY OF RAKTAMOKSHANA AND SHAMANA CHIKITSA IN THE AYURVEDIC MANAGEMENT OF INDRALUPTA (ALOPECIA AREATA): A CASE REPORT
Ayurvedic treatment successfully regrew hair in a 19-year-old with alopecia areata in 2 months.
research A Persuasive in the Management of Indralupta (Alopecia areata) with Ayurvedic approach
Leech therapy and Ayurvedic treatment can effectively regrow hair in recent Alopecia areata cases.
research Parasurgical Management of Indralupta (Alopecia Areata) by Jalaukavcharana (Leech Therapy): A Case Report
Leech therapy effectively treated a young girl's patchy hair loss with minimal complications.
research Clinical Outcome of Ayurvedic Management of Indralupta (Alopecia Areata)- A Case Study
Ayurvedic treatment may help manage alopecia areata.
research Clinical Evaluation of Prachchhana Karma and Supportive Ayurvedic Medication in the Management of Indralupta (Alopecia Areata): a Case Study
Prachchhana Karma and Ayurvedic medication can help treat patchy hair loss.
Community Join
5 / 1000+ resultscommunity Self-Experiment - Topical Rapamycin or a-KB
A user plans to create a DIY topical treatment for hair loss using Rapamycin, possibly combined with alpha-ketoglutaric acid (a-KG). They discuss the concentration and formulation process for Rapamycin, considering safety and skin penetration, and intend to apply it every other day to the scalp.
community Kintor Pharma Announces Completion of Subject Enrollment and Dosing in Phase I Clinical Trial of AR-PROTAC(GT20029) in the US_Kintor Pharmaceutical Limited
Kintor Pharma finished enrolling and dosing participants in a Phase I trial for a hair loss treatment called AR-PROTAC (GT20029). The effectiveness of another drug, pyrilutamide (KX-826), for hair loss will be clearer after a Phase 2 trial expected to complete in January 2023.
community Ruxolitinib - Start of a case study
The conversation is about a user trying a new hair loss treatment, Ruxolitinib, alongside their existing regimen of finasteride, minoxidil, ketoconazole shampoo, and microneedling. They plan to apply Ruxolitinib to their temples daily for 1-2 months.
community Kintor Pharma Announces Completion of Subject Enrollment in Phase III Clinical Trial of KX-826 for Treatment of Male Androgenetic Alopecia
Kintor Pharma completed enrolling subjects for a Phase III trial of KX-826 for male hair loss treatment. The trial includes a 24-week treatment period and a 4-week safety follow-up, with results expected in about 6-7 months.
community Kintor is starting a new phase III KX-826 combined with Minoxidil
Kintor is starting a phase III trial for KX-826 combined with minoxidil for hair loss. Opinions vary on the potential success of the treatment, with some skepticism expressed.